Rapid Switch From Flolan to Remodulin in the Outpatient ClinicStudy of Intravenous Remodulin in Patients in India With Pulmonary Arterial HypertensionSafety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinSafety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) SubjectsAn Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionTrial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial HypertensionInhaled Treprostinil for PAH: Open-label ExtensionSafety and Efficacy of Inhaled Treprostinil in Patients With PAHAddition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®Long Term Safety and Efficacy of Ralinepag in Pulmonary Arterial HypertensionA Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsPatient Global Impression Questions for Activity-induced Symptoms in Patients With PAHInhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
P859
Q61914607-AFA781FC-3B90-4666-BA1C-2AFB1A7C23B5Q61917681-2F40DCFE-D4CA-4617-ACC8-C693350BC50FQ61932794-B300C28A-6CE9-409E-AC98-5C80198BFFC7Q63062656-F919941C-D8DA-4BA7-8E8C-C42E5AF9D093Q63316626-D3C89F7D-15AA-4149-8FD4-5A9671D2741FQ63316631-F3368203-A084-4A49-849B-C8C978AE26DDQ63317731-9A8F6CBC-A805-400A-B793-58316B62266BQ63317736-37299EA4-E18A-4376-B116-B06D0A673F5AQ63320544-4FB06993-1DA2-4530-997B-121EB5217896Q63571425-C04FF3CC-A75C-42A0-8E84-230F050A9EE8Q63573808-6C02A8FF-ED8D-4F8D-B02A-E0233D973506Q63581180-AFC8D73B-0F76-4ABF-9018-5A45B3DA0A9FQ63593406-F0D552D4-1F5D-4CD5-85D3-01CCF7247754
P859
description
americká firma
@cs
biotech company based in Silver Spring, Maryland, United States
@en
name
United Therapeutics
@en
type
label
United Therapeutics
@en
prefLabel
United Therapeutics
@en
P3153
P159
P213
0000 0004 0411 3117
P2427
grid.421987.1
P31
P3153
P3417
United-Therapeutics-company
P3500
P373
United Therapeutics
P452
P571
1996-01-01T00:00:00Z